Cytokinetics Inc CYTK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
65.27UNCH (UNCH)
Volume
23,902
Close
65.27quote price arrow up+0.93 (+1.45%)
Volume
876,298
52 week range
25.98 - 110.25
Loading...
  • Open66.08
  • Day High66.61
  • Day Low65.00
  • Prev Close64.34
  • 52 Week High110.25
  • 52 Week High Date01/08/24
  • 52 Week Low25.98
  • 52 Week Low Date10/04/23

Key Stats

  • Market Cap6.826B
  • Shares Out104.58M
  • 10 Day Average Volume1.24M
  • Dividend-
  • Dividend Yield-
  • Beta0.81
  • YTD % Change-21.82

KEY STATS

  • Open66.08
  • Day High66.61
  • Day Low65.00
  • Prev Close64.34
  • 52 Week High110.25
  • 52 Week High Date01/08/24
  • 52 Week Low25.98
  • 52 Week Low Date10/04/23
  • Market Cap6.826B
  • Shares Out104.58M
  • 10 Day Average Volume1.24M
  • Dividend-
  • Dividend Yield-
  • Beta0.81
  • YTD % Change-21.82

RATIOS/PROFITABILITY

  • EPS (TTM)-5.45
  • P/E (TTM)-11.97
  • Fwd P/E (NTM)-14.67
  • EBITDA (TTM)-484.313M
  • ROE (TTM)-572.15%
  • Revenue (TTM)7.53M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-6,988.63%
  • Debt To Equity (MRQ)-160.14%

EVENTS

  • Earnings Date05/08/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cytokinetics Inc

 

Profile

MORE
Cytokinetics, Incorporated is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. The Company specializes in muscle biology and the mechanics of muscle performance. It is developing small molecule drug candidates specifically engineered to...
John Henderson M.D.
Independent Chairman of the Board
Robert Blum
President, Chief Executive Officer, Director
Robert Wong
Chief Accounting Officer, Vice President
Fady Malik M.D., Ph.D.
Executive Vice President - Research and Development
Andrew Callos
Executive Vice President, Chief Commercial Officer
Address
350 Oyster Point Boulevard
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
PCVX
Vaxcyte Inc
65.96+1.41+2.18%
RVMD
Revolution Medicines Inc
40.20+1.01+2.58%
IBRX
Immunitybio Inc
9.15+0.18+2.01%
CERE
Cerevel Therapeutics Holdings Inc
42.55-0.04-0.09%
VKTX
Viking Therapeutics Inc
76.97+1.21+1.60%